• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Eculizumab for the treatment of pregnancy-related atypical hemolytic uremic syndrome.

作者信息

Cañigral Carolina, Moscardó Federico, Castro Cristina, Pajares Azucena, Lancharro Aima, Solves Pilar, de la Rubia Javier, Carpio Nelly, Sanz Miguel A

机构信息

Hematology Department, Hospital Universitari i Politècnic La Fe, Bulevard Sur s/n, Valencia, 46026, Spain.

出版信息

Ann Hematol. 2014 Aug;93(8):1421-2. doi: 10.1007/s00277-013-1970-3. Epub 2013 Dec 5.

DOI:10.1007/s00277-013-1970-3
PMID:24306089
Abstract
摘要

相似文献

1
Eculizumab for the treatment of pregnancy-related atypical hemolytic uremic syndrome.依库珠单抗治疗妊娠相关非典型溶血性尿毒症综合征。
Ann Hematol. 2014 Aug;93(8):1421-2. doi: 10.1007/s00277-013-1970-3. Epub 2013 Dec 5.
2
Relapse of aHUS after discontinuation of therapy with eculizumab in a patient with aHUS and factor H mutation.1例伴有补体H因子突变的非典型溶血尿毒综合征（aHUS）患者停用依库珠单抗治疗后aHUS复发。
Ann Hematol. 2013 Jun;92(6):845-6. doi: 10.1007/s00277-012-1622-z. Epub 2012 Nov 15.
3
Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome.依库珠单抗治疗非典型溶血尿毒综合征。
N Engl J Med. 2013 Jun 6;368(23):2169-81. doi: 10.1056/NEJMoa1208981.
4
Early diagnosis and management of postpartum hemolytic uremic syndrome with plasma exchange.产后溶血性尿毒症综合征的早期诊断及血浆置换治疗
Transfus Apher Sci. 2011 Jun;44(3):257-62. doi: 10.1016/j.transci.2011.04.004. Epub 2011 May 6.
5
Successful treatment of the postpartum atypical hemolytic uremic syndrome with eculizumab.用依库珠单抗成功治疗产后非典型溶血性尿毒症综合征。
Ann Intern Med. 2013 Jul 2;159(1):76. doi: 10.7326/0003-4819-159-1-201307020-00023.
6
Eculizumab for atypical hemolytic uremic syndrome in pregnancy.依库珠单抗治疗妊娠相关性非典型溶血尿毒综合征。
Obstet Gynecol. 2013 Aug;122(2 Pt 2):487-489. doi: 10.1097/AOG.0b013e31828e2612.
7
Eculizumab as first-line therapy for atypical hemolytic uremic syndrome.依库珠单抗作为一线治疗用于非典型溶血性尿毒症综合征。
Pediatrics. 2014 Jun;133(6):e1759-63. doi: 10.1542/peds.2013-1787.
8
Successful discontinuation of eculizumab therapy in a patient with aHUS.一名非典型溶血性尿毒症综合征患者成功停用依库珠单抗治疗。
Ann Hematol. 2014 Aug;93(8):1423-5. doi: 10.1007/s00277-013-1972-1. Epub 2013 Dec 18.
9
[HTA-pre-eclampsia-postpartum haemolytic-uraemic syndrome: good results can be achieved].[高血压前期-子痫前期-产后溶血性尿毒症综合征：可取得良好疗效]
Nefrologia. 2010;30(5):593-4. doi: 10.3265/Nefrologia.pre2010.Jun.10479.
10
Cryptic activity of atypical hemolytic uremic syndrome and eculizumab treatment.非典型溶血尿毒综合征的隐匿性活动和依库珠单抗治疗。
Pediatrics. 2014 Jun;133(6):e1769-71. doi: 10.1542/peds.2013-2921. Epub 2014 May 19.

引用本文的文献

1
Complement-mediated hemolytic uremic syndrome associated with postpartum hemorrhage: case series and systematic review of individual participant data.与产后出血相关的补体介导的溶血性尿毒症综合征：病例系列及个体参与者数据的系统评价
Res Pract Thromb Haemost. 2024 Oct 3;8(8):102579. doi: 10.1016/j.rpth.2024.102579. eCollection 2024 Nov.
2
A Life-Threating Postpartum Atypical Hemolytic-Uremic Syndrome with Multiorgan Involvement.一例危及生命的产后非典型溶血性尿毒症综合征伴多器官受累
J Clin Med. 2022 Nov 25;11(23):6957. doi: 10.3390/jcm11236957.
3
Complement gene variant effect on relapse of complement-mediated thrombotic microangiopathy after eculizumab cessation.
补体基因变异对依库珠单抗停药后补体介导的血栓性微血管病复发的影响。
Blood Adv. 2023 Feb 14;7(3):340-350. doi: 10.1182/bloodadvances.2021006416.
4
Complement Blockade Is a Promising Therapeutic Approach in a Subset of Critically Ill Adult Patients with Complement-Mediated Hemolytic Uremic Syndromes.补体阻断是治疗一部分由补体介导的溶血尿毒综合征成年危重症患者的一种有前景的治疗方法。
J Clin Med. 2022 Feb 1;11(3):790. doi: 10.3390/jcm11030790.
5
Atypical hemolytic uremic syndrome: when pregnancy leads to lifelong dialysis: a case report and literature review.非典型溶血性尿毒症综合征：妊娠导致终身透析的病例报告及文献综述
Cardiovasc Endocrinol Metab. 2021 Mar 17;10(4):225-230. doi: 10.1097/XCE.0000000000000247. eCollection 2021 Dec.
6
Thrombotic microangiopathy in aHUS and beyond: clinical clues from complement genetics.血栓性微血管病在 aHUS 及其他疾病中的作用：补体遗传学的临床线索。
Nat Rev Nephrol. 2021 Aug;17(8):543-553. doi: 10.1038/s41581-021-00424-4. Epub 2021 May 5.
7
Pregnancy-Associated Atypical Hemolytic Uremic Syndrome: A Systematic Review.妊娠相关性非典型溶血尿毒综合征：系统评价。
Obstet Gynecol. 2020 Jan;135(1):46-58. doi: 10.1097/AOG.0000000000003554.
8
Eculizumab, a novel potential treatment for acute kidney injury associated with preeclampsia/HELLP syndrome.依库珠单抗，一种用于治疗与子痫前期/HELLP综合征相关的急性肾损伤的新型潜在疗法。
BMJ Case Rep. 2019 Sep 5;12(9):e228709. doi: 10.1136/bcr-2018-228709.
9
Eculizumab prevents thrombotic microangiopathy in patients with atypical haemolytic uraemic syndrome in a long-term observational study.在一项长期观察性研究中，依库珠单抗可预防非典型溶血性尿毒症综合征患者的血栓性微血管病。
Clin Kidney J. 2018 May 16;12(2):196-205. doi: 10.1093/ckj/sfy035. eCollection 2019 Apr.
10
Eculizumab in paroxysmal nocturnal haemoglobinuria and atypical haemolytic uraemic syndrome: 10-year pharmacovigilance analysis.依库珠单抗治疗阵发性睡眠性血红蛋白尿症和非典型溶血尿毒综合征：10 年药物警戒分析。
Br J Haematol. 2019 Apr;185(2):297-310. doi: 10.1111/bjh.15790. Epub 2019 Feb 15.